Diphenhydramine vs Pembrolizumab
Diphenhydramine vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Diphenhydramine and Pembrolizumab.
Mechanism of Action
Diphenhydramine: First-generation H1 antihistamine with anticholinergic properties.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Diphenhydramine — 2-8 hours; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Diphenhydramine — C17H21NO.
Molecular Weight: Diphenhydramine — 255.3550 g/mol.
Type: Diphenhydramine — Small molecule; Pembrolizumab — Antibody.